Relpax and Stadol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax and Stadol. Common interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people who take Relpax and Stadol have. It is created by eHealthMe based on reports of 11 people who take Relpax and Stadol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

11 people who take Relpax and Stadol together, and have interactions are studied.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 8,804 Relpax users for its effectiveness, alternative drugs and more.

What is Stadol?

Stadol has active ingredients of butorphanol tartrate. It is often used in migraine. eHealthMe is studying from 5,524 Stadol users for its effectiveness, alternative drugs and more.

Number of Relpax and Stadol reports submitted per year:

Common Relpax and Stadol drug interactions by gender *:

female:

Drug ineffective
Nausea
Amnesia
Anxiety
Arthralgia
Bipolar disorder
Brain neoplasm
Candidiasis
Cholelithiasis
Constipation

male:

n/a

Common Relpax and Stadol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Adjustment disorder
Brain neoplasm
Candidiasis
Cholelithiasis
Constipation
Dependent personality disorder
Diabetes mellitus
Drug abuse
Dysthymic disorder
Dysuria

40-49:

Arthralgia
Drug ineffective
Face oedema
Fatigue
Hypersomnia
Malaise
Oedema
Oedema peripheral
Pain in extremity
Sensation of heaviness

50-59:

Abdominal distension
Dyspnoea
Fatigue
Flight of ideas
Gastrooesophageal reflux disease
Headache
Hypertension
Insomnia
Muscle spasms
Nausea

60+:

Drug ineffective

Common conditions people have *:

Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Depression: 2 people, 18.18%
Insomnia (sleeplessness): 2 people, 18.18%
Bleeding Into The Skin: 2 people, 18.18%
Peripheral Swelling: 2 people, 18.18%
Skin Fissures (a crack in the skin): 2 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 9.09%
Dizziness: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Stadol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.